Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
Status:
NOT_YET_RECRUITING
Trial end date:
2030-07-01
Target enrollment:
Participant gender:
Summary
This is a sub-study of the S. aureus Network Adaptive Platform (SNAP) trial (NCT05137119) wherein we will evaluate whether not giving rifampin in patients with probable or definite prosthetic valve endocarditis due to S. aureus is non-inferior to giving rifampin.
Phase:
PHASE3
Details
Lead Sponsor:
Todd C. Lee MD MPH FIDSA
Collaborators:
Canadian Institutes of Health Research (CIHR) McGill University Health Centre/Research Institute of the McGill University Health Centre The Peter Doherty Institute for Infection and Immunity University of Melbourne